| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 2.64e-05 | 5 | 33 | 2 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 2.64e-05 | 5 | 33 | 2 | GO:0015501 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.17e-04 | 296 | 33 | 5 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.26e-04 | 301 | 33 | 5 | GO:0022853 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.99e-04 | 758 | 33 | 7 | GO:0015318 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 2.04e-04 | 13 | 33 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 2.04e-04 | 13 | 33 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.62e-04 | 793 | 33 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 2.74e-04 | 15 | 33 | 2 | GO:0005313 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 4.94e-04 | 20 | 33 | 2 | GO:0015172 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 6.56e-04 | 23 | 33 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 9.28e-04 | 465 | 33 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | transporter activity | 9.58e-04 | 1289 | 33 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 9.75e-04 | 28 | 33 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.04e-03 | 477 | 33 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 1.05e-03 | 29 | 33 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 1.20e-03 | 31 | 33 | 2 | GO:0005310 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.25e-03 | 129 | 33 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 1.27e-03 | 32 | 33 | 2 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 1.27e-03 | 32 | 33 | 2 | GO:0005452 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.33e-03 | 293 | 33 | 4 | GO:0008514 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.51e-03 | 138 | 33 | 3 | GO:0015297 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.52e-03 | 35 | 33 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | symporter activity | 1.92e-03 | 150 | 33 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.96e-03 | 151 | 33 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.96e-03 | 151 | 33 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 2.09e-03 | 41 | 33 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.62e-03 | 46 | 33 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 2.72e-03 | 1180 | 33 | 7 | GO:0022857 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.79e-03 | 171 | 33 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.44e-03 | 627 | 33 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 4.39e-03 | 664 | 33 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.76e-03 | 207 | 33 | 3 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.83e-03 | 208 | 33 | 3 | GO:0005342 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 6.13e-03 | 71 | 33 | 2 | GO:0015179 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 6.65e-03 | 459 | 33 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 7.91e-03 | 81 | 33 | 2 | GO:0015370 | |
| GeneOntologyMolecularFunction | channel activity | 1.06e-02 | 525 | 33 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.06e-02 | 526 | 33 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.30e-02 | 105 | 33 | 2 | GO:0015171 | |
| GeneOntologyBiologicalProcess | L-aspartate import across plasma membrane | 3.48e-05 | 6 | 32 | 2 | GO:0140009 | |
| Domain | Na-dicarboxylate_symporter | 5.94e-05 | 7 | 32 | 2 | IPR001991 | |
| Domain | SDF | 5.94e-05 | 7 | 32 | 2 | PF00375 | |
| Domain | - | 5.94e-05 | 7 | 32 | 2 | 1.10.3860.10 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 5.94e-05 | 7 | 32 | 2 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 5.94e-05 | 7 | 32 | 2 | PS00714 | |
| Domain | Na-dicarboxylate_symporter_CS | 5.94e-05 | 7 | 32 | 2 | IPR018107 | |
| Domain | Channel_four-helix_dom | 4.28e-03 | 57 | 32 | 2 | IPR027359 | |
| Domain | - | 4.28e-03 | 57 | 32 | 2 | 1.20.120.350 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.70e-06 | 108 | 27 | 5 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.78e-06 | 109 | 27 | 5 | MM15074 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 7.84e-05 | 238 | 27 | 5 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 9.70e-05 | 249 | 27 | 5 | M5988 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 9.50e-04 | 24 | 27 | 2 | MM14834 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 9.50e-04 | 24 | 27 | 2 | M630 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 29741614 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 16647773 | ||
| Pubmed | Differential roles of glial and neuronal glutamate transporters in Purkinje cell synapses. | 8.73e-07 | 2 | 33 | 2 | 16177048 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 17221839 | ||
| Pubmed | Inositol 1,4,5-trisphosphate signaling maintains the activity of glutamate uptake in Bergmann glia. | 2.62e-06 | 3 | 33 | 2 | 20958799 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 28173092 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 17727989 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 22424243 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 9379843 | ||
| Pubmed | Impact of Reduced Cerebellar EAAT Expression on Purkinje Cell Firing Pattern of NPC1-deficient Mice. | 5.23e-06 | 4 | 33 | 2 | 29463856 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 9129177 | ||
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 34093381 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.23e-04 | 271 | 33 | 4 | 32433965 | |
| Pubmed | 2.18e-04 | 23 | 33 | 2 | 10706615 | ||
| Pubmed | NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. | 3.02e-04 | 27 | 33 | 2 | 23359859 | |
| Pubmed | SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses. | 3.68e-04 | 147 | 33 | 3 | 33080218 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 3.75e-04 | 148 | 33 | 3 | 32538781 | |
| Cytoband | 16p13.3 | 7.19e-04 | 244 | 33 | 3 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 1.51e-03 | 316 | 33 | 3 | chr3p21 | |
| Cytoband | 3p21.31 | 2.37e-03 | 100 | 33 | 2 | 3p21.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 3.52e-03 | 426 | 33 | 3 | chr16p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p13 | 4.52e-03 | 139 | 33 | 2 | chr5p13 | |
| GeneFamily | Solute carriers | 9.40e-05 | 395 | 22 | 5 | 752 | |
| GeneFamily | Olfactory receptors, family 1 | 1.07e-03 | 40 | 22 | 2 | 147 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.41e-07 | 185 | 33 | 5 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-07 | 193 | 33 | 5 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-07 | 193 | 33 | 5 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-06 | 125 | 33 | 4 | b1a12400f7070bdf09e87974c548a8b82e92b65e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 186 | 33 | 4 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 187 | 33 | 4 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-05 | 189 | 33 | 4 | 0a490730cdc912d5233de59057550de0e4065747 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 191 | 33 | 4 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 191 | 33 | 4 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 194 | 33 | 4 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 194 | 33 | 4 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.32e-05 | 197 | 33 | 4 | 836fcb20d3a1f9cf14f6fd505fbb6bad4650fd28 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.32e-05 | 197 | 33 | 4 | 902e2ce011a938c1de39ff53ebbb2ec5557e48bc | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.35e-05 | 110 | 33 | 3 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.67e-04 | 145 | 33 | 3 | f6ba6cf0c8d0ee87a7904485b27eb9261fcb6edd | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-04 | 149 | 33 | 3 | 68661c8facfb638560bb2e2c20d509941286dacb | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.03e-04 | 155 | 33 | 3 | 1020da8a2c30384d962fa204a030299fdfcbbf98 | |
| ToppCell | severe-Myeloid-pDC|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.27e-04 | 161 | 33 | 3 | 9e8e8ac11f7fb8c8697357c21034b613f191db2b | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 161 | 33 | 3 | da9eecf919866a9c579d7a707a996cf335213134 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 161 | 33 | 3 | d431625c32f59a6b552191f3adc5198bd16ad5cf | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-04 | 162 | 33 | 3 | ec29c6f1c31e41ddcb041a49c593910edaf0532c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.31e-04 | 162 | 33 | 3 | 6ffcf369d954c20ce036aa1d072cee4e205f728e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.31e-04 | 162 | 33 | 3 | bcbf7f80a2a1c80def795e345f16cf16e8b9d03b | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.31e-04 | 162 | 33 | 3 | 233011408f022647932c81ebab78f9813e3c6833 | |
| ToppCell | severe-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.48e-04 | 166 | 33 | 3 | ae38850fde549b8dd6fb12f0ef80b428ade50485 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-04 | 166 | 33 | 3 | f4698fd08965936d51695d571bd10fb77330d916 | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 2.75e-04 | 172 | 33 | 3 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | mild-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.95e-04 | 176 | 33 | 3 | 59a9c262c252b7d220a025837922d98e9d6b0a24 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 2.95e-04 | 176 | 33 | 3 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-04 | 177 | 33 | 3 | 76f5df101c693e5fa61554244d877fc8169ee66f | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-erythroid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.99e-04 | 177 | 33 | 3 | b647667da62a91dbe3890820142626e26aa779d2 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.04e-04 | 178 | 33 | 3 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-04 | 179 | 33 | 3 | d0fa700648db8ce76a8aa689879a25048299fa40 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-04 | 179 | 33 | 3 | 2e49b215b71438400aebb483f2c2c08d5e956961 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-04 | 179 | 33 | 3 | dfd5b25f2a6a5a8bf4714f1516cb0997de72b06f | |
| ToppCell | mild-Myeloid-pDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.15e-04 | 180 | 33 | 3 | 38614155fa537d0defda914c531c697be0ef06d8 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.15e-04 | 180 | 33 | 3 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.15e-04 | 180 | 33 | 3 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.20e-04 | 181 | 33 | 3 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-04 | 182 | 33 | 3 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-04 | 183 | 33 | 3 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.30e-04 | 183 | 33 | 3 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.30e-04 | 183 | 33 | 3 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 3.35e-04 | 184 | 33 | 3 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.41e-04 | 185 | 33 | 3 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 185 | 33 | 3 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.41e-04 | 185 | 33 | 3 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | control-Myeloid-pDC|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.46e-04 | 186 | 33 | 3 | fe31e9cf4575ee40b50489593c51d8c36c3cc532 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-04 | 187 | 33 | 3 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-04 | 187 | 33 | 3 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-04 | 187 | 33 | 3 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 188 | 33 | 3 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | severe_COVID-19-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 3.63e-04 | 189 | 33 | 3 | 8037fd4d799d95d9ca633a3efaf698539f696893 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 189 | 33 | 3 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 189 | 33 | 3 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-04 | 189 | 33 | 3 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 3.63e-04 | 189 | 33 | 3 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-04 | 189 | 33 | 3 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 3.68e-04 | 190 | 33 | 3 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-04 | 190 | 33 | 3 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.68e-04 | 190 | 33 | 3 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.74e-04 | 191 | 33 | 3 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.74e-04 | 191 | 33 | 3 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.74e-04 | 191 | 33 | 3 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.74e-04 | 191 | 33 | 3 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.74e-04 | 191 | 33 | 3 | 752e31a4b8aab9243b0451f4c40c2940ae9a5252 | |
| ToppCell | severe_COVID-19-CD4+_Tcm|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.74e-04 | 191 | 33 | 3 | 1ec86eaf90411ed200dbf51ae0cb5ed8060a7ec7 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-04 | 191 | 33 | 3 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class (2021.01.30) | 3.74e-04 | 191 | 33 | 3 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.74e-04 | 191 | 33 | 3 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 3.74e-04 | 191 | 33 | 3 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 3.74e-04 | 191 | 33 | 3 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.74e-04 | 191 | 33 | 3 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-04 | 191 | 33 | 3 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.74e-04 | 191 | 33 | 3 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-04 | 191 | 33 | 3 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-04 | 191 | 33 | 3 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.74e-04 | 191 | 33 | 3 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 3.74e-04 | 191 | 33 | 3 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.80e-04 | 192 | 33 | 3 | 71bc03b08cda0382ea45b503d5f4f135ed98cc11 | |
| ToppCell | URO-Lymphocyte-T_NK-CD8_TEM|URO / Disease, Lineage and Cell Type | 3.80e-04 | 192 | 33 | 3 | 31b6d068f7adc6952c4cf625df851a10cb1b00c9 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 192 | 33 | 3 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.86e-04 | 193 | 33 | 3 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.86e-04 | 193 | 33 | 3 | f492ed02a46f3a45dc6005f9f18ab12a84bfa2a3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.86e-04 | 193 | 33 | 3 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | COVID-19_Severe-CD4+_Tcm|COVID-19_Severe / disease group, cell group and cell class | 3.86e-04 | 193 | 33 | 3 | 45fe14c10b71459047608c8931d83c9c533f97f9 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD4+_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.86e-04 | 193 | 33 | 3 | ebb22400b683a7d135448822ad2a32cb1059e104 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD8_TEM|ICU-SEP / Disease, Lineage and Cell Type | 3.92e-04 | 194 | 33 | 3 | 5dbf0e3d8ccc389220f1fceaa2e99c85a1c4d818 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.92e-04 | 194 | 33 | 3 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD8_TEM|Int-URO / Disease, Lineage and Cell Type | 3.92e-04 | 194 | 33 | 3 | e35bf4ef39e377bd0f56e5020a4c016ba66b8570 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-04 | 194 | 33 | 3 | 70185c0b8e0f4e896645b17a243482ba3cdf4a5d | |
| ToppCell | Healthy-CD8+_Tem|World / disease group, cell group and cell class | 3.97e-04 | 195 | 33 | 3 | 3d6f46b31c0254e9577a560364694b42964df198 | |
| ToppCell | mild_COVID-19|World / disease group, cell group and cell class (v2) | 3.97e-04 | 195 | 33 | 3 | 6dbe9db5f0e94f2e91b3d1282855d200051ab0ba | |
| ToppCell | Healthy_donor-CD8+_Tem|World / disease group, cell group and cell class (v2) | 4.03e-04 | 196 | 33 | 3 | b04684d319d0c462862677d0f956a389bffef535 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.03e-04 | 196 | 33 | 3 | c06caba0c91b8ee66f42bc43ec75eb2475f07056 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.03e-04 | 196 | 33 | 3 | 093fb240e72911dfd360aa6edf8ed2d611c78a1e | |
| ToppCell | Healthy/Control-CD8+_Tem|World / Disease group and Cell class | 4.03e-04 | 196 | 33 | 3 | a6dc92476156a695e15373ea57dc04e30014ac55 | |
| ToppCell | normal-na-Hematopoietic|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.03e-04 | 196 | 33 | 3 | c2c1c894706428bad5bfc81e9ae0f921ab1286d3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.03e-04 | 196 | 33 | 3 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.09e-04 | 197 | 33 | 3 | 33d841f4fcff8aeb0b988d5dd072166347bc6022 | |
| Computational | Genes in the cancer module 186. | 1.79e-04 | 20 | 11 | 2 | MODULE_186 | |
| Drug | phenylgermanium | 2.04e-06 | 2 | 33 | 2 | CID006396940 | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 1.81e-05 | 6 | 33 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | hair colour measurement | 5.67e-04 | 615 | 33 | 5 | EFO_0007822 | |
| Disease | Bipolar Disorder | 1.90e-03 | 477 | 33 | 4 | C0005586 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 1.93e-03 | 58 | 33 | 2 | EFO_0022338 | |
| Disease | response to opioid | 2.13e-03 | 61 | 33 | 2 | EFO_0008541 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 2.27e-03 | 63 | 33 | 2 | EFO_0022283 | |
| Disease | alcohol consumption measurement | 2.29e-03 | 1242 | 33 | 6 | EFO_0007878 | |
| Disease | age-related macular degeneration, COVID-19 | 2.72e-03 | 69 | 33 | 2 | EFO_0001365, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TLPGIAHLVVETMIV | 391 | P48751 | |
| TAVGIPEVMSRLEVV | 431 | P11597 | |
| MLSLLPEVVVLVGVT | 186 | Q96P56 | |
| IQSIVDGMEPTVTLL | 426 | Q6ZP65 | |
| TTEVPVLVMVTPINE | 426 | A6H8M9 | |
| IIVAIMETNPSILEV | 741 | O75154 | |
| ITVLEMTPVLGTEII | 331 | Q9NQX3 | |
| TLMVTGLTPEELAVT | 1601 | P51610 | |
| ELVMFTVGVVVITLP | 196 | Q8NGS2 | |
| DSTVLPGILIEMSEV | 211 | Q9NPJ1 | |
| IMGNTTILTVIRTEP | 41 | Q8NH59 | |
| PELLVTRVVEISIME | 181 | Q9HCN3 | |
| EVIILSEGALVMITP | 196 | O43749 | |
| VVDTVILPSMIGIIC | 31 | Q969V1 | |
| VIPVGTTMDKVVEIL | 341 | Q96SD1 | |
| MVIVLTSVGLPTDDI | 451 | P43003 | |
| MVIVLTSVGLPTEDI | 476 | P48664 | |
| TSTPTIMDIVVIAGV | 51 | P04921 | |
| IAMVVPDSTLIAEII | 1926 | Q9P225 | |
| ETILVELEIMSPLGI | 601 | Q01668 | |
| RFPIPTEMIVVVVAT | 281 | Q7LBE3 | |
| EVVEAVTIVETPPMV | 71 | P39023 | |
| VTIVETPPMVVVGIV | 76 | P39023 | |
| MPVSSLIVGVDLVPI | 66 | Q8IY81 | |
| PPMTVETISKVIVIE | 3651 | P08F94 | |
| VLTTVMITVVHERVP | 91 | Q8NHU3 | |
| LVITPQIPMVTEEFV | 6 | Q6P9A3 | |
| ILIVPMGATSILIDE | 201 | O95428 | |
| VLTEPILIETYTGLM | 241 | Q6ZUI0 | |
| VTITGETLEIPDTVM | 356 | Q71RS6 | |
| ETLEIPDTVMGLTLL | 361 | Q71RS6 | |
| EVVVPLTVELMGTVA | 51 | P49765 | |
| SAVEPTLMVIKEPII | 576 | Q8N9V7 | |
| MQVTITLTSPIIREE | 861 | Q96KR1 | |
| METVVIVAIGVLATI | 1 | Q9Y2Y6 |